BioHealth News Archive
Nature publishes Mimetas gut-on-a-chip model
I'm thrilled to let you know that our gut-on-a-chip work has been published this week in Nature Communications. 350 mini-guts on-a-chip, 20,000 data points, the…
Read MoreGlaxoSmithKline opens new $56.6M vaccines plant in Scotland – FiercePharma
GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab. But the…
Read MoreCreatv MicroTech Awarded NIH SBIR Grant for Precision Medicine Diagnostic for Lung Cance
Creatv MicroTech, a biotechnology company developing noninvasive diagnostics for cancer, has received a $250,000 Small Business Innovation Research (SBIR) grant from the National Institutes…
Read MoreOpen House For Fall Technology Transfer Courses at the FAES Graduate School at NIH
Join us on Thursday, August 24 for the 2017-18 Fall Term FAES Graduate School Open House to meet and mingle with FAES faculty. Bring yourself,…
Read MoreJohn Delaney, Maryland Democrat, to run for president on innovation, entrepreneurship – Washington Times
Once considered a potential Democratic challenger to Maryland Gov. Larry Hogan next year, John Delaney has set his sights higher — much higher. The…
Read MoreAssociate Scientist—Analytics – BioFactura
Job Summary: BioFactura is seeking highly motivated applicants with an entrepreneurial spirit for an open position in our biosimilar development programs. We are looking…
Read MoreEntrepreneur Expo – Get The Early Bird Tickets by September 15, 2017!
Wed, October 25, 2017 PITCH. NETWORK. LEARN. BE INSPIRED. TEDCO’s 7th Annual Entrepreneur Expo will bring together all of Maryland’s entrepreneurial resources from across…
Read MoreLupin’s alliance partner Natco receives FDA approval for generic Fosrenol Chewable Tablets
Pharma major Lupin Limited (Lupin) and Natco announced the final ANDA approval of Lanthanum Carbonate Chewable Tablets 500 mg (base), 750 mg (base), and…
Read MoreU.S. FDA REMOVES CLINICAL HOLD ON CEL-SCI’S PHASE 3 HEAD & NECK CANCER TRIAL
CEL-SCI Corporation (NYSE American: CVM) today announced it has received a letter from the U.S. Food and Drug Administration (FDA) stating that the clinical…
Read MoreStudy Results Published in The Lancet Demonstrate Safety and Efficacy of Intrathecal VTS-270 in Niemann-Pick Disease Type C1
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the publication of results from a Phase 1/2a study of intrathecal administration of…
Read MoreMaxCyte Appoints 25-Year Biopharma Industry Veteran as EVP of Global Marketing
25-year biopharma industry veteran joins the Company to drive further growth of its innovative high-performance cell engineering platform for use in commercial drug development…
Read MoreHealth IT startups to watch in 2017: A running list – Healthcare IT News
From companies created to work in best in today's new value-based healthcare system to precision medicine, data analytics and interoperability, you can count on…
Read MoreCardin: BioPark “A Priority of Our State” – University of Maryland, Baltimore
U.S. Sen. Benjamin L. Cardin, JD ‘67, returned to his alma mater, the University of Maryland, Baltimore (UMB), to tour the UM BioPark and…
Read MoreMaryland Colleges: Which Grads Make The Most Money – Annapolis, MD Patch
You don't have to go to Johns Hopkins University to make a lot of money. In fact, you can make more money by going…
Read MoreNIH budget cuts will damage ‘The American System’
The Trump administration is pushing for dramatic cutbacks at the National Institutes of Health. The proposed $5.8 billion cut from the agency's annual $32…
Read More